Doctor Chaowu Yan

Doctor Chaowu Yan

Fuwai Hospital, CAMS and PUMC, Beijing (China)

Yan Chaowu, PhD and MD, Chief-physician in Fuwai hospital (National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China). The major was the diagnosis and interventional treatment of structural heart disease. My interests mainly focused on the pulmonary arterial hypertension associated with congenital heart disease, TAVR and other innovations about interventional cardiology.

Presentations Articles

Indirect evaluation of device-endothelialization with cardiac-CT after transcatheter closure of atrial septal defect: How long should antiplatelet therapy last postoperatively?

Event: ESC Congress 2020

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Interventional Cardiology ePosters

Access

Transfemoral-venous transcatheter access to left ventricle through the created communication of inter-ventricular septum with the assistance of arterio-venous circuit

Event: ESC Congress 2020

Topic: Aortic Valve Intervention

Session: Interventional Cardiology ePosters

Access

The combined use of radiofrequency-ablation and balloon-dilation (CURB) in the creation of a stable inter-atrial communication: fist-in-man use for patients with severe pulmonary arterial hypertension

Event: ESC Congress 2019

Topic: Intervention

Session: New treatments for pulmonary vascular disease

Access

Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

Event: ESC Congress 2018

Topic: Intervention

Session: Drug therapy in congenital heart disease - What are the options and the needs?

Access

Diastolic pulmonary arterial pressure as a prognostic indicator for closure of atrial septal defect with severe pulmonary arterial hypertension

Event: ESC Congress 2016

Topic: GUCH and paediatric cardiology, others

Session: Congenital heart disease

Access

Application of three-dimensional printing in the transcatheter closure of secundum atrial septal defect with deficient posterior-inferior rim

Event: ESC Congress 2016

Topic: Non coronary cardiac interventions

Session: Atrio-ventricular valve intervention

Access

Indirect evaluation of device-endothelialization with cardiac-CT after transcatheter closure of atrial septal defect: How long should antiplatelet therapy last postoperatively?

Event: ESC Asia with APSC & AFC 2020

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Abstract Programme

Access

Doctor Chaowu Yan

Biography

Contributor content

Indirect evaluation of device-endothelialization with cardiac-CT after transcatheter closure of atrial septal defect: How long should antiplatelet therapy last postoperatively?

Transfemoral-venous transcatheter access to left ventricle through the created communication of inter-ventricular septum with the assistance of arterio-venous circuit

The combined use of radiofrequency-ablation and balloon-dilation (CURB) in the creation of a stable inter-atrial communication: fist-in-man use for patients with severe pulmonary arterial hypertension

Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

Diastolic pulmonary arterial pressure as a prognostic indicator for closure of atrial septal defect with severe pulmonary arterial hypertension

Application of three-dimensional printing in the transcatheter closure of secundum atrial septal defect with deficient posterior-inferior rim

Indirect evaluation of device-endothelialization with cardiac-CT after transcatheter closure of atrial septal defect: How long should antiplatelet therapy last postoperatively?

ESC 365 is supported by